Presenter Title

Presenter name

Living Our Mission in All We Do

alleviate pain

restore health

extend life−written in 1960

Cardiac and Vascular Group

$8.8B

Strengthened by Our Breadth

Restorative Therapies Group $6.5B

Cardiac rhythm disease management

Structural heart

CoronarySurgical technologies

Neuromodulation

Spine

EndovascularDiabetes Group

$1.7B

FY2014 Revenue by Business

$17 Billion

Transforming to Meet Changing Needs

Therapy innovation Globalization Economic value

Medtronic strategies

Growingchronic disease

Broadening stakeholders

Rising cost and healthcare reform

Universal healthcare needs Improved clinical

outcomesExpanded

accessOptimized cost and efficiency

Market dynamics

Applying Core Technologies to Advance Medical Therapy

Electrical stimulation

Targeted drug and biologics delivery

Implantable structural devices

Surgical navigation and imaging

Powered and advanced energy instruments

Patient and device management

Diabetes

Neurological

Spinal and orthopedic

Ear, nose and throat

Structural heart

Urological, urogynecological and gastroenterological

Endovascular 

Coronary

Cardiac rhythm

Severe spasticityParkinson’s disease Essential tremor Dystonia*Hydrocephalus Obsessive-compulsive disorder*  Brain tumors and lesions Chronic pain Subdural hematomas Cranial trauma 

Cervical degenerative disc disease  Scoliosis  Degenerative disc disease Spinal fracture Lumbar spinal stenosis Tibial fractures Orthopedic trauma

Sinus diseases  Thyroid conditions Otologic disorders Sleep-disordered breathing Pediatric conditionsMénière’s disease

Heart valve disease Congenital heart disease

Overactive bladder and urinary retention Nausea and vomiting associated with gastroparesis* Fecal incontinence

Peripheral vascular disease  Aortic aneurysms 

Coronary artery disease

Atrial fibrillation  Slow heart rates (bradycardia) Fast heart rates (tachycardia) Heart failure  Asymptomatic heart rates 

Alleviating Chronic Conditions

* Humanitarian device in the United States – the effectiveness for this use has not been demonstrated as of FY14. As of FY14

Delivering Innovative Solutions Around the World

Latin America Middle East / Africa

Central / Eastern Europe

Greater China

United States

Asia Pacific

Western Europe / Canada South Asia

international sales 46% countriescountries140+locationslocations260+

strategic regionsstrategic regions9

Japan

Leading the Way

lives improved

350+ clinical trials

40+medical conditions

27,000+ patents

5,600scientists &

engineers

$67Mtotal charitable

contributions

49,000+ employees

$17Brevenue

another life is improved

Every seconds3

10M+

lives improved

350+ clinical trials

40+medical conditions

23,000+ patents

5,800scientists &

engineers

$64Mtotal charitable

contributions

46,000+ employees

$16.6Brevenue

9M+

another life is improved

Every seconds3